BMS, rendition of the new site in Leiden, Netherlands

Bris­tol My­ers finds a home for 1st EU cell ther­a­py site, clear­ing land near Am­s­ter­dam air­port for easy lo­gis­tics

As Bris­tol My­ers Squibb con­tin­ues to scale its CAR-T op­er­a­tions, the New York drug gi­ant will open up its first cell man­u­fac­tur­ing site in Eu­rope — and it’s tapped space near the Am­s­ter­dam air­port as its home.

The com­pa­ny is set to build a new cell ther­a­py site in Lei­den and lever­age the life sci­ences com­mu­ni­ty near the air­port for con­ve­nient ac­cess for ship­ping pa­tient cells. Fi­nan­cial terms were not dis­closed.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.